New treatment for cognitive impairment

Israel’s Therapix Biosciences has developed a unique tablet for sublingual (under the tongue) administration of THC. A clinical trial of this tablet is anticipated to commence early 2017 for treatment of impairments in cognitive functioning, including early stages of Alzheimer’s disease.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *